A citation-based method for searching scientific literature

Jose A Santiago, Judith A Potashkin. Trends Mol Med 2013
Times Cited: 140

Alexander Harkavyi, Amjad Abuirmeileh, Rebecca Lever, Ann E Kingsbury, Christopher S Biggs, Peter S Whitton. J Neuroinflammation 2008
Times Cited: 199

List of shared articles

Times cited

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight.
Giulia Monti, Diana Gomes Moreira, Mette Richner, Henricus Antonius Maria Mutsaers, Nelson Ferreira, Asad Jan. Cells 2022

Understanding the links between cardiovascular disease and Parkinson's disease.
Judy Potashkin, Xuemei Huang, Claudia Becker, Honglei Chen, Thomas Foltynie, Connie Marras. Mov Disord 2020

The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease.
Julia L Y Cheong, Eduardo de Pablo-Fernandez, Thomas Foltynie, Alastair J Noyce. J Parkinsons Dis 2020

Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model.
Yanwei Li, WeiZhen Liu, Lin Li, Christian Hölscher. Neuropharmacology 2016

Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Henrik H Hansen, Katrine Fabricius, Pernille Barkholt, Jens D Mikkelsen, Jacob Jelsing, Charles Pyke, Lotte Bjerre Knudsen, Niels Vrang. Brain Res 2016